Franziskus Hospital Bielefeld GGmbH

Bielefeld, Germany

Franziskus Hospital Bielefeld GGmbH

Bielefeld, Germany
SEARCH FILTERS
Time filter
Source Type

Grober U.,Akademie fur Mikronahrstoffmedizin | Mucke R.,Klinikum Lippe GmbH | Mucke R.,Ruhr University Bochum | Adamietz I.A.,Ruhr University Bochum | And 5 more authors.
Onkologe | Year: 2013

Context: Many patients being treated for cancer use micronutrient supplements with the intention to complement the cancer treatment or help them cope with the therapy and disease-associated side-effects. Up to 90 % of cancer patients supplement with antioxidants without the knowledge of the treating physician. Methods: Alternatives to textbook medicine were assessed from published scientific data and otherwise available information, e.g. homepages, ESPEN-Guidelines. Results: There are many concerns that antioxidants might decrease the effectiveness of chemotherapy but increasing evidence suggests a benefit when antioxidants and other micronutrients, such as selenium, L-carnitine and vitamin D are added to conventional cytotoxic therapies. Conclusion: However, it is imperative that physicians explore the use of antioxidant and other micronutrient supplements with cancer patients and educate them about potentially negative and also potentially beneficial effects. © 2013 Springer-Verlag Berlin Heidelberg.

Loading Franziskus Hospital Bielefeld GGmbH collaborators
Loading Franziskus Hospital Bielefeld GGmbH collaborators